EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Emotional response to amyloid beta status disclosure among research participants at high dementia risk

Sapir Golan Shekhtman iD, Michal Schnaider Beeri, Ramit Ravona Springer, Maya Zadok, Mery Ben Meir, Yael Rosen-Lang, Revital Shutsberg, Dar Gelblum, Tal Niv, Adar Matatov, Anthony Heymann, Joseph Azuri und 4 weitere

Alzheimer's & Dementia · 2025

DOI: 10.1002/alz.70115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Sapir Golan Shekhtman und 15 weiteren Autor:innen. Beteiligte Einrichtung: The Joseph Sagol Neuroscience Center, Sheba Medical Center, Ramat Gan, Israel. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Emotions, Dementia, Disclosure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Alzheimer's Association, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Amyloid beta (Aβ) can be detected in vivo years before Alzheimer's disease (AD) symptom onset and, according to recent criteria, is sufficient for a biological diagnosis. This study evaluates emotional responses to Aβ status disclosure in cognitively normal individuals. METHODS Questionnaires were given before and 6 months after Aβ positron emission tomography results disclosure to assess anxiety and depression related to the possibility of an elevated result, subjective memory complaints, and motivation for risk‐reduction behavior. RESULTS One hundred ninety‐nine cognitively normal adults were included. Non‐elevated Aβ status disclosure was associated with reductions in all emotional parameters compared to baseline ( p < 0.001). Elevated Aβ disclosure was associated with no changes in depression or memory complaints and a modest decrease in anxiety and motivation to change lifestyle ( p < 0.048). DISCUSSION No negative psychological effects were observed after Aβ status disclosure. Decreased motivation for lifestyle changes was seen after disclosure of both elevated and non‐elevated amyloid status and should be targeted. Highlights No negative psychological effects were observed after amyloid beta (Aβ) status disclosure. Motivation for lifestyle changes decreased after Aβ disclosure. Lower education may predict “unfavorable” response to non‐elevated Aβ disclosure. Results support personalized communication strategies for Aβ disclosure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid beta-PeptidesEmotionsDementiaDisclosureHumansMaleFemaleAgedPositron-Emission TomographyMiddle AgedSurveys and QuestionnairesDepressionAnxietyMotivation

Stichwörter der Autor:innen

Alzheimer's diseaseamyloid betaamyloid beta positron emission tomography imagingamyloid beta status disclosureanxietycognitively normal individualsdepressionemotional responsesmotivation for risk‐reduction behaviorobservational trialssubjective memory complaints

Substanzen

Amyloid beta-Peptides

Autor:innen und Institutionen

  • The Joseph Sagol Neuroscience Center, Sheba Medical Center, Ramat Gan, Israel.
  • Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Krieger Klein Alzheimer's Research Center, Brain Health Institute, Piscataway, New Jersey, USA.
  • Memory Clinic, Sheba Medical Center, Ramat Gan, Israel.
  • Department of Family Medicine, Maccabi Health Services, Tel Aviv, Israel.
  • Neurology Department, Sheba Medical Center, Ramat Gan, Israel.

ORCID-Profile: Sapir Golan Shekhtman

Förderung

  • NIA NIH HHS
  • Alzheimer's Association
  • National Institute on Aging

Zitieren

APA

Golan Shekhtman, S., Beeri, M. S., Springer, R. R., Zadok, M., Ben Meir, M., Rosen-Lang, Y., Shutsberg, R., Gelblum, D., Niv, T., Matatov, A., Heymann, A., Azuri, J., Ganmore, I., Hoffman, C., Domachevsky, L., & Lesman-Segev, O. H. (2025). Emotional response to amyloid beta status disclosure among research participants at high dementia risk. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70115

Vancouver

Golan Shekhtman S, Beeri MS, Springer RR, Zadok M, Ben Meir M, Rosen-Lang Y, et al. Emotional response to amyloid beta status disclosure among research participants at high dementia risk. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70115

BibTeX
@article{GolanShekhtman2025,
  author = {Golan Shekhtman, Sapir and Beeri, Michal Schnaider and Springer, Ramit Ravona and Zadok, Maya and Ben Meir, Mery and Rosen-Lang, Yael and Shutsberg, Revital and Gelblum, Dar and Niv, Tal and Matatov, Adar and Heymann, Anthony and Azuri, Joseph and Ganmore, Ithamar and Hoffman, Chen and Domachevsky, Liran and Lesman-Segev, Orit H},
  title = {Emotional response to amyloid beta status disclosure among research participants at high dementia risk},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  doi = {10.1002/alz.70115}
}
Kostenlos starten →